chartexchange

PYXS
Pyxis Oncology, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:56 PM EST
1.58USD0.000%(0.00)359,905
After-hoursNov 13, 2026 4:51:30 PM EST
1.5754USD-0.291%(-0.0046)
Loading…
Loading…
188.98M
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$1.58
Beta
1.25
52-Week High
$5.55 2025-11-26
52-Week Low
$1.03 2025-12-26
SMA 50
$2.36
SMA 200
$2.16
Avg. Vol 10D
800,730
Avg. Vol 30D
914,122
Avg. Vol 90D
1.13M
Relative Vol
0.39
119.61M
37.25M
0.6000%
2,900,000
PYXS Profile

pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment.

PYXS Performance
PeriodPriceDateChangeBeta
1W1.662026-11-06-4.82%2.376
1M1.852026-10-13-14.60%1.549
3M3.012026-08-13-47.51%1.240
6M2.622026-05-13-39.70%0.367
1Y4.482025-11-13-64.73%1.246
2Y4.282024-11-13-63.08%—
5Y11.822021-11-12-86.63%1.095
PYXS Stock Summary

Pyxis Oncology, Inc. Common Stock (NASDAQ:PYXS) stock price today is $1.58, and today's volume is 359,905. PYXS is up 0.000% today. The 30 day average volume is 914,122. PYXS market cap is $188.98M with 119.61M shares outstanding.